Patents by Inventor Kerry Anne Cleek

Kerry Anne Cleek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6870070
    Abstract: The present invention relates to (2S)-enantiomers of 2-aminoindan derivatives of formula I: and a novel process for the preparation of them.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: March 22, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Arthur Glenn Romero, Thomas Andrew Runge, Bradley D. Hewitt, Kjell Anders Ivan Svensson, Chiu-Hong Lin, Kerry Anne Cleek, Susanne R. Haadsma-Svensson
  • Publication number: 20020151596
    Abstract: The present invention relates to (2S)-enantiomers of 2-aminoindan derivatives of formula I: 1
    Type: Application
    Filed: April 29, 2002
    Publication date: October 17, 2002
    Inventors: Arthur Glenn Romero, Thomas Andrew Runge, Bradley D. Hewitt, Kjell Anders Ivan Svensson, Chiu-Hong Lin, Kerry Anne Cleek, Susanne R. Haadsma-Svensson
  • Patent number: 6410787
    Abstract: The present invention relates to (2S)-enantiomers of 2-aminoindan derivatives of formula I: and a novel process for the preparation of them.
    Type: Grant
    Filed: February 14, 2001
    Date of Patent: June 25, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Arthur Glenn Romero, Thomas Andrew Runge, Bradley D. Hewitt, Kjell Anders Ivan Svensson, Chiu-Hong Lin, Kerry Anne Cleek, Susanne R. Haadsma-Svensson
  • Publication number: 20010044471
    Abstract: The present invention relates to (2S)-enantiomers of 2-aminoindan derivatives of formula I: 1
    Type: Application
    Filed: February 14, 2001
    Publication date: November 22, 2001
    Inventors: Arthur Glenn Romero, Thomas Andrew Runge, Bradley D. Hewitt, Kjell Anders Ivan Svensson, Chiu-Hong Lin, Kerry Anne Cleek, Susanne R. Haadsma-Svensson
  • Patent number: 6084130
    Abstract: Compounds and their pharmaceutically acceptable salts suitable for treating central nervous system disorders associated with the dopamine D3 receptor activity of structural Formula I: ##STR1##
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: July 4, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Arthur Glenn Romero, William Harold Darlington, Jeffrey A. Leiby, Chiu-Hong Lin, Susanne R. Haadsma-Svensson, Kerry Anne Cleek